Home / Medications / JanumetMedicationsJanumet FDA Issues Advisory for Januvia, Janumet Submitted by Staff on September 25, 2009 – 4:33pm Average: 4 The FDA is revising the prescribing information for Januvia (sitagliptin) and Janumet (sitagliptin/metformin) to include information on reported cases of acute pancreatitis in patients using these products. Type 2 Diabetes Pancreatitis Diabetes Patient Safety/Education Janumet Januvia FDA Recalls and Alerts Read more Previous ArticleNamendaNext ArticleEvista
